Charcoal and Charcoal-based Toothpastes
Charcoal and charcoal-containing products, such as toothpastes, are popular among the public. Nevertheless, its safety and efficacy has not yet been proven and the long-term effects are not completely known.

CHARCOAL AND ITS USE IN COSMETICS

Charcoal and charcoal-based toothpastes and products for teeth are becoming more and more popular. It is easy to find toothpastes containing charcoal in drug stores, pharmacies and online websites.

Charcoal is the dried, carbonaceous material obtained from the heating of organic substances. In cosmetics and personal care products, charcoal is used as an abrasive, absorbent, deodorant and opacifying agent. Besides cosmetic products, these ingredients are also used in other areas (e.g., as a colourant in food).

The fine black powder obtained by burning animal bones in a closed container (charcoal, bone) is used as a colourant in cosmetic products and it consists primarily of a mixture of carbon, calcium phosphate and calcium carbonate. It is included in Annex IV (list of colourants allowed in cosmetic products) of the European Regulation (EC) No 1223/2009 and when used to impart colour to cosmetics in the European Union, this ingredient is called CI 77267.

The type of charcoal that is usually used in tooth products is ‘activated charcoal’ and it consists in a fine grain powder made from wood, coconut shells and other natural substances that are oxidized under extreme heat.

The fine grain of charcoal contained in toothpaste works as a gentle/mild abrasive and may help to remove surface stains on teeth or absorb surface stains to some degree. It does not have any action in intrinsic stains, below the enamel. Activated charcoal might be too abrasive for a daily use, wearing down the enamel, exposing the dentine and resulting in tooth sensitivity. Toothpastes containing charcoal don’t usually contain fluoride, which is an important substance for teeth protection against cavities and decay. These products may also stain older teeth and its effects on dental restorations are not completely known.

Regarding the safety and effectiveness of tooth whitening products, the American Dental Association (ADA) states that whitening can only be achieved either by bleaching with peroxide or by using a polishing/chemical agent that removes surface stains. Moreover, according to ADA, there is no evidence showing that dental products with charcoal are safe or effective for teeth. A literature review published in the Journal of the American Dental Association (JADA) in 2017 reaffirmed and supported this conclusion. The results of the literature review showed insufficient clinical and laboratory data to substantiate the safety and efficacy claims of charcoal and charcoal-based dentifrices. Studies, at larger-scale and better designed, are needed to establish conclusive evidence. It is advised for patients to be cautious when using these products.

In sum, charcoal dentifrices may help in surface stains, but their efficacy and safety are yet to be demonstrated. Caution should be taken in using this type of products.

If you have any doubts or wish to get more information about toothpaste formulation and its ingredients’ safety profile, do not hesitate to contact us at info@criticalcatalyst.com.

References:

  1. Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products.
  2. Charcoal and charcoal-based dentifrices – A literature review. 2017. The Journal of the American Dental Association (JADA). Available at: https://jada.ada.org/article/S0002-8177(17)30412-9/abstract#%20
  3. Charcoal Toothpaste for Teeth Whitening: The Pros and Cons. Healthline. Available at: https://www.healthline.com/health/dental-and-oral-health/charcoal-toothpaste

further
reading

medical devices

Amendments to the Transitional Provisions of the European Union MDR and IVDR

The proposed amendments aim to maintain patients’ access to a wide range of medical devices while ensuring the transition to the new framework. The ammendments proposal aims to extend the current transition period (Article 120 of the MDR), and it also deletes the ‘sell-off’ deadlines of both MDR and IVDR. The extension is staggered depending on the risk class of the device – until December 2027 for high-risk devices and December 2028 for medium and lower-risk devices.

Read More »
medical devices

EU MDR – Proposal for Extension of Transition Period

The transition to MDR has been slower than anticipated by the European Commission. Insufficient capacity of notified bodies and the low level of preparedness of manufacturers led to a proposal for extension of current MDR transition period with deadlines depending on the risk class of the devices.

Read More »
medical devices

MDCG 2022-18 – EU MDR Article 97

EU MDR Article 97 may be a temporary solution to avoid disruption of supply of Medical Devices on the EU Market. The MDCG 2022-18 presents a uniform approach for application of MDR Article 97 on non-compliant legacy devices under the conditions set by the competent authorities, while limiting the impact on the supply of safe and effective devices.

Read More »
parfum_fragrance_allergen_1
cosmetic products

EU to set Labelling Requirements for 56 additional Fragrance Allergens in Cosmetic Products

World Trade Organization (WTO) has been notified by the European Commission of a draft amendment to Regulation (EC) No 1223/2009 as regards labelling of fragrance allergens in Cosmetic Products. The proposed date of adoption of the new regulation is expected to be in the first half of 2023 and the propose date of entry in force 20 days from the publication in the Official Journal of the European Union.

Read More »
cosmetic products

New Amendments to the European Cosmetics Regulation – CMR Substances

The European Commission published the Commission Regulation (EU) 2022/1531, which amends Regulation (EC) No 1223/2009 in regards to the use in cosmetic products of certain substances classified as CMR. This amendment introduces new entries to Annex II and Annex III and revises an entry to Annex V to Regulation (EC) No 1223/2009.

Read More »
medical devices

EUDAMED – harmonized practices and alternative solutions for IVDR until the database is fully functional

EUDAMED is one of the key aspects of the new rules on in vitro diagnostic medical devices – Regulation (EU) 2017/746. However, it is only expected to achieve full functionality by the second quarter of 2024. Until then, how is the information submitted and/or exchanged between manufacturers, notified bodies and competent authorities?

Read More »
medical devices

EUDAMED – update on timelines

EUDAMED is one of the key aspects of the new rules on medical devices (Regulation (EU) 2017/745) and in vitro diagnostic medical devices (Regulation (EU) 2017/746), and it is expected to achieve full functionality by the second quarter of 2024.

Read More »
cosmetic products

UK OPSS call for data on six cosmetic ingredients

On 14 July 2022, the Office for Product Safety and Standards (OPSS – the UK regulator for cosmetic products) issued a call for data on the safety of the following six cosmetic ingredients to investigate any suspected endocrine disrupting properties. 

Read More »